ClinicalTrials.Veeva

Menu

Oxyntomodulin, Mechanisms of Action in Relation to Appetite, Food Intake, Gastric Emptying and Energy Expenditure.

U

University Hospital, Gentofte, Copenhagen

Status

Completed

Conditions

Incretin Action
Obesity

Treatments

Other: GLP-1 and glucagon infusion
Other: Glucagon infusion
Other: Oxyntomodulin infusion
Other: GLP-1 infusion
Other: Placebo

Study type

Observational

Funder types

Other

Identifiers

NCT01232244
OXMDissek

Details and patient eligibility

About

Tiny molecules (hormones) are released from the bowels and other organs to the bloodstream in response to meals in order to orchestrate the metabolism. Oxyntomodulin, GLP-1 and glucagon are all known to regulate parameters such as appetite, food intake and induce weight loss.

Therefore we want to investigate mechanistic relations between the three hormones.

Enrollment

15 patients

Sex

Male

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Normal fasting plasma glucose
  • Normal glucose tolerance
  • Normal haemoglobin levels
  • Informed content

Exclusion criteria

  • Diabetes
  • Pre diabetes (impaired glucose tolerance or impaired fasting glucose)
  • 1st degree relatives with diabetes
  • Obesity (BMI > 30)
  • Inflammatory bowels disease
  • Bowels surgery
  • Nephropathy
  • Liver disease
  • Medication which cannot be on hold for 24h

Trial design

15 participants in 1 patient group

Healthy young males
Treatment:
Other: GLP-1 infusion
Other: Glucagon infusion
Other: Placebo
Other: GLP-1 and glucagon infusion
Other: Oxyntomodulin infusion

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems